- Home
- AMLX vs NLOP Comparison
AMLX vs NLOP Comparison
Compare AMLX & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- NLOP
- Stock Information
- Founded
- AMLX 2014
- NLOP N/A
- Country
- AMLX United States
- NLOP United States
- Employees
- AMLX N/A
- NLOP N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- NLOP
- Sector
- AMLX Health Care
- NLOP
- Exchange
- AMLX Nasdaq
- NLOP Nasdaq
- Market Cap
- AMLX 459.1M
- NLOP 474.6M
- IPO Year
- AMLX 2022
- NLOP N/A
- Fundamental
- Price
- AMLX $7.68
- NLOP $33.36
- Analyst Decision
- AMLX Strong Buy
- NLOP Strong Buy
- Analyst Count
- AMLX 8
- NLOP 1
- Target Price
- AMLX $11.00
- NLOP $46.00
- AVG Volume (30 Days)
- AMLX 2.1M
- NLOP 79.9K
- Earning Date
- AMLX 08-07-2025
- NLOP 01-01-0001
- Dividend Yield
- AMLX N/A
- NLOP 1.02%
- EPS Growth
- AMLX N/A
- NLOP N/A
- EPS
- AMLX N/A
- NLOP N/A
- Revenue
- AMLX N/A
- NLOP $127,453,000.00
- Revenue This Year
- AMLX N/A
- NLOP N/A
- Revenue Next Year
- AMLX N/A
- NLOP N/A
- P/E Ratio
- AMLX N/A
- NLOP N/A
- Revenue Growth
- AMLX N/A
- NLOP N/A
- 52 Week Low
- AMLX $1.76
- NLOP $23.38
- 52 Week High
- AMLX $7.72
- NLOP $34.38
- Technical
- Relative Strength Index (RSI)
- AMLX 75.73
- NLOP 52.40
- Support Level
- AMLX $5.97
- NLOP $32.19
- Resistance Level
- AMLX $6.86
- NLOP $33.01
- Average True Range (ATR)
- AMLX 0.54
- NLOP 0.50
- MACD
- AMLX 0.13
- NLOP -0.13
- Stochastic Oscillator
- AMLX 98.29
- NLOP 14.94
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.